POSA282 Oncology Drugs without Phase III Data: Comparison of Reimbursement Recommendations Issued by the Canadian Agency for Drugs and Technologies in Health (CADTH), and the National Institute for Health and Care Excellence (NICE)

POSA282 Oncology Drugs without Phase III Data: Comparison of Reimbursement Recommendations Issued by the Canadian Agency for Drugs and Technologies in Health (CADTH), and the National Institute for Health and Care Excellence (NICE)

Saved in:
Bibliographic Details
Published in:Value in health Vol. 25; no. 1; pp. S174 - S175
Main Authors: Singh, S, Hachborn, G, Jarrett, K, Pericleous, L, Benyo, S, Maoloni, M
Format: Journal Article
Language:English
Published: Elsevier Inc 01-01-2022
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1098-3015
1524-4733
DOI:10.1016/j.jval.2021.11.849